Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
28.87
-0.65 (-2.20%)
At close: Mar 6, 2026, 4:00 PM EST
28.60
-0.27 (-0.94%)
After-hours: Mar 6, 2026, 4:52 PM EST
Rigel Pharmaceuticals Employees
As of December 31, 2024, Rigel Pharmaceuticals had 164 total employees, including 162 full-time and 2 part-time employees. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
$1,794,402
Profits / Employee
$2,237,951
Market Cap
533.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 265 |
| Allogene Therapeutics | 229 |
| Prothena Corporation | 163 |
| Alpha Tau Medical | 125 |
| Solid Biosciences | 100 |
| Invivyd | 100 |
| Ocugen | 95 |
| Neumora Therapeutics | 95 |
RIGL News
- 3 days ago - Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 11 days ago - Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - PRNewsWire
- 4 weeks ago - Rigel Appoints Michael P. Miller to the Board of Directors - PRNewsWire
- 5 weeks ago - Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 - Seeking Alpha
- 7 weeks ago - Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Rigel Provides Business Update and 2026 Outlook - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire